Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Twitter Based Social Support for Hispanic and Black Dementia Caregivers (Tweet-S2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03865498
Recruitment Status : Not yet recruiting
First Posted : March 7, 2019
Last Update Posted : April 13, 2020
Sponsor:
Collaborator:
Department of Health and Human Services
Information provided by (Responsible Party):
Sunmoo Yoon, Columbia University

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The prevalence of dementia is higher in Hispanics and African Americans than non-Hispanic Whites. Moreover, dementia caregivers often experience loneliness as well decreased health status. The expansion of social media use among Hispanics and African Americans, particularly Twitter - a short message service - offers great promise for improving social support. This study aims to evaluate changes of discussion topics, sentiment and networking styles (i.e., number of followers) among anonymous followers of our two Twitter networks; the African American/Black dementia caregiver group and the Hispanic dementia caregiver group.

Condition or disease Intervention/treatment Phase
Loneliness Emotional Stress Behavioral: Twitter for Hispanic caregivers Behavioral: Twitter for African American caregivers Not Applicable

Detailed Description:
The study will utilize Twitter networks to post a daily message for dementia caregivers for a year, and set up a monthly group chat.
Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 800 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Using Twitter to Enhance the Social Support of Hispanic and Black Dementia Caregivers
Estimated Study Start Date : September 2021
Estimated Primary Completion Date : November 2022
Estimated Study Completion Date : November 2022

Resource links provided by the National Library of Medicine


Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: Hispanic dementia caregivers
De-identified followers of our Hispanic dementia caregiver Twitter network will receive messages from the network (Twitter for Hispanic caregivers' intervention).
 Behavioral: Twitter for Hispanic caregivers
This group will be asked to follow and use (i.e., retweet, reply, like) our Hispanic Twitter network for social support
Experimental: African American dementia caregivers
De-identified followers of our African American dementia caregiver Twitter network will receive messages from the network (Twitter for African American caregivers' intervention).
 Behavioral: Twitter for African American caregivers
This group will be asked to follow and use (i.e., retweet, reply, like) our African American Twitter network for social support.


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Fraction of isolates [ Time Frame: 12 months ]
    % of the people who do not engage Twitter activities (i.e., retweet, reply, like, post) within the Twitter network for dementia caregivers: macro-level. 0% indicates no social isolates and 100% indicates all users with no Twitter activities.

  2. Emotional valence score [ Time Frame: 12 months ]
    Emotional valence (macro level) detected from text data (e.g., "This is so helpful" - emotion score +4, "I am sad"- emotion score -6). Emotional valence score ranges from -10 to +10; -10 indicates negative valence (bad) and +10 indicates positive valence (good).


Secondary Outcome Measures :
  1. Number of auto-detected small groups [ Time Frame: 12 months ]
    Meso level: number of small group automatically detected based on Twitter activities (i.e., retweet); for example 0 means no small-group activity detected, 7 small groups mean seven distinct cliques/grouping activities detected where the users are communicating, supporting and responding within our Twitter network.

  2. Number of individual posting activities with balanced communication type [ Time Frame: 12 months ]
    Micro level: balanced communication triad, 2 or 3 people responding and communicating with equal or similar frequency; 0 reflects non-optimal communication indicating domination, avoidance or ignorance. 8 means there are 8 triads who maintain healthy communication.


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • 18 years of age or older
  • Black or Hispanic, living in the U.S. including the U.S. territories
  • a dementia caregiver with any duration, able to speak English or Spanish/bilingual
  • must agree to terms of conditions of use and privacy policy and rules of one of the two dementia caregiver network (Hispanic @dcnh, Black @dcnaab), the Twitter user agreement of the terms of service, Twitter privacy policy and Twitter rules including intellectual property, violence, misconduct, abuse behavior, private information and spam and security
  • use a smartphone or a feature phone (i.e., a cell phone with text messaging)

Exclusion Criteria:

  • do not have de-identified Twitter account, children, not a dementia family caregiver
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03865498


Contacts
Layout table for location contacts
Contact: Sunmoo Yoon, PhD 212-300-7081 sy2102@cumc.columbia.edu

Locations
Layout table for location information
United States, New York
Columbia University
New York, New York, United States, 10032
Contact: Sunmoo Yoon, PhD    212-300-7081    sy2102@cumc.columbia.edu   
Principal Investigator: Sunmoo Yoon, PhD         
Sponsors and Collaborators
Columbia University
Department of Health and Human Services
Investigators
Layout table for investigator information
Principal Investigator: Sunmoo Yoon, PhD Associate Research Scientist in the Department of Medicine
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Sunmoo Yoon, Associate Research Scientist, Columbia University
ClinicalTrials.gov Identifier: NCT03865498    
Other Study ID Numbers: AAAS3305
First Posted: March 7, 2019    Key Record Dates
Last Update Posted: April 13, 2020
Last Verified: April 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Sunmoo Yoon, Columbia University:
Family Caregivers
Dementia
Additional relevant MeSH terms:
Layout table for MeSH terms
Dementia
Stress, Psychological
Brain Diseases
Central Nervous System Diseases
 Nervous System Diseases
Neurocognitive Disorders
Mental Disorders
Behavioral Symptoms